STEK — what changed in the latest 10-Q
A section-by-section comparison of STEK's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-14 vs the prior 10-Q · 2026-06-22
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +18 | −15 | ~7 | 25 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 1 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 1 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-14
In February 2026, the Company launched the Stemtech BioSciences e-commerce retail platform. This platform is intended to expand the Company's retail distribution channels beyond its traditional network marketing model and increase direct consumer access to the Company's products. Management expects …
Commission expense decreased by $72,456, or 59.8%, from $121,210 for the three months ended June 30, 2025 to $48,754 for the three months ended June 30, 2026. The decrease was primarily attributable to a shift in revenue mix during the quarter. During the three months ended June 30, 2026, the Compan…
General and administrative expenses decreased by $158,268 from $697,987 to $539,719. This reduction reflects management's ongoing cost management initiatives, including reductions in personnel costs, professional fees, and overhead.
During the three months ended June 30, 2026 and 2025, total non-operating expense (income) was $(166,791) and $4,708, respectively. Interest expense increased to $112,734 for the three months ended June 30, 2026, from $79,727 for the same period in 2025. During the three months ended June 30, 2026, …
Interest expense for the three months ended June 30, 2026 was $112,734, compared to $79,727 for the same period in 2025.
Text removed vs the prior filing · source: 10-Q · 2026-06-22
Commission expense decreased by $140,619, from $185,558 to $44,939, primarily as a direct consequence of the decline in net sales, as commissions are largely variable and paid as a percentage of revenue generated by the Company’s independent distributor network.
General and administrative expenses decreased by $328,450 from $1,727,367 to $1,398,917. This reduction reflects management’s ongoing cost management initiatives, including reductions in personnel costs, professional fees, and overhead, partially offset by stock-based compensation expense of $101,06…
During the three months ended March 31, 2026 and 2025, total non-operating expenses were $158,631 and $253,821, respectively, reflecting a decrease of $90,798.
Interest expense decreased significantly to $97,659 for the three months ended March 31, 2026, from $245,368 for the same period in 2025, a reduction of $147,709. This decrease reflects the partial extinguishment of outstanding convertible debt through equity conversions completed during the quarter…
Our net loss for the three months ended March 31, 2026 was $1,252,880, compared to a net loss of $1,458,726 for the same period in 2025. Despite a significant decline in net sales, the net loss improved by $205,846, or 14.1%, period over period. This improvement was primarily driven by a reduction i…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice